Friday, September 3, 2010

How does Dr. Donato Perez Garcia,MD services and Hospital stands

The opinion of the son in law of a cancer patients about the family experience of being treated in Tijuana by Dr. Donato Perez Garcia,MD. (September 2, 2010)

 

Comment by Donato Perez Garcia,MD
IPT or IPTLD is not a product that comes in a Box and the trained IPT doctor opens and mixes it to deliver. 

IPTLD/IPT is a service provided by a talented, trained, educated and experienced, medical doctor that requires him/her to know the principles of pre treating your body with insulin and what it does and then to know the different chemo drugs, which ones can be combined and their possible side effects.  Pre treating a patient with insulin helps to potentiate or enhance the effect of that chemo drug and this means that resistance is minimized. 

The combination of chemo drugs I choose are based on several factors for each patient, age, sex, allergies, diet habits, exercise and activity history, among some and I choose the best ones that the pharmaceutical companies consider their best ones. Of course the amount I choose is considerably less than what the manufacturer recommends because I am using it in combination with the potentiating effect of insulin. 
If the patient has a cancer recurrence and is concerned with the combination that I will use I can tell you and assure you that during my more than 28 years of practicing IPTLD/IPT (something none of my IPT students worldwide have) I have seen that patients that were told they were resistant to XYZ chemotherapy drug they respond when used along with insulin. If the patient comes with tests -sensitivity- done on the tissue or the blood that reports which ones are effective, I take a look and have them as plan B, C, D, etc, because these tests are done for the standard chemotherapy dosages not for the IPTLD/IPT protocol; when these tests consider the chemical-physical changes insulin produces then the tests will definitely be more accurate to be used with IPT/IPTLD. 
I can use from 2 to 4 different chemotherapy drugs

Wednesday, September 1, 2010

A matter of perfect timing to receive your low dose chemo with IPTLD

Visual Description of your morning IPTLD treatment with
Donato Perez Garcia,MD
in Tijuana, Baja California, Mexico.

Mrs. Walser (from Germany) was video taped on the morning of Monday August 30, 2010 to produce small video clips that show what you will experience while under my professional care.

--- o ---

She Registers with the Cashier, leaves a deposit  and sign's the consent forms
--- o ---

While Mrs Walser is registering, Nurses are getting ready to take care of her.
 
--- o ---

Mrs Walser is taken to the out patient care room area and placed in a private room.
 
--- o ---

The Nurse prepares all material that will be used for the administration of the IPTLD & Hyperthermia treatments.
 
--- o ---

The patient is prepared, first body weight and vital signs
 
--- o ---

The Nurse administers the IM medication
  
--- o ---

The Nurse is finishing setting the IV, BP & Pulse measure & oximether
 
--- o ---

The Hyperthermia blanket is placed and turned on up to 41 Celsius or 105.8 Fahrenheit
 
--- o ---

The Nurse fills all syringes and marks its content.
--- o ---

Nurse and Doctor makes sure the IV is working and placed inside a vein.
--- o ---

The patient receives the low dose of rapid acting Insulin and the time is recorded as well as the blood pressure, pulse, temperature, oxigen saturation and the heart rate is monitored.
--- o ---

When the induced hypoglycemia, referred as to the Therapeutic Moment is reached, the blood sugar is measured
 
--- o ---

 
--- o ---

 
--- o ---

--- o ---

 
--- o ---

--- o ---

--- o ---

 
--- o ---

 
--- o ---

--- o ---

 
--- o ---
 
--- o ---

 
--- o ---

 
--- o ---

 
--- o ---

------- o-------

Finally the good news: Email sent on September 2, 2010
Hello Dr. Donato.
I just got the good news from my thermography. There is no sign of new growth.
Finally, some concrete info. Thank you for your great work.
See you soon.
Helma

Timing of cancer chemotherapy is crucial for the success of treatment

Timing of cancer chemotherapy is crucial for the success of treatment


Back in the year 1980, R. North an immunologist from the Trudeau Institute in New York and colleagues were able to produce immune cycling with tumor regression by directing chemotherapy to immune suppressor cells. He also reported that if chemotherapy was given at the wrong day and earlier, it will not work, instead the tumor will grow faster and will give the impression that the tumor was resistant to the chemotherapy drug. (Science Magazine,May 2010)

While several of the IPT doctors that I have trained on Insulin Potentiation Therapy  (IPT)  and some patients who have a cancer recurrence are concerned with finding which chemotherapy drug will work best I tell them that to have a successful treatment of cancer depends on the accurate timing of delivering chemotherapy to match the fluctuation in each patient's immune system.

Not all cancer patients are cured by surgery, radiotherapy, biological therapies, alternative treatments, standard high dose chemotherapy or even low dose chemo. Some patients achieve a complete regression, others do not respond and others appear to have some level of clinical response.

Traditional cancer therapies affect some cancer cells but also normal cells and produce the well known side effects.

Today September 2010, my Insulin Potentiation Therapy +Targeted Low Dose chemotherapy has been taking advantage of the immune system cycle using it's regulatory mechanism by enhancing selectively the T cells in a cycle specific manner due to the actions of the insulin that acts as a modifier of the cell biologic response. Insulin enhances (potentiates) the anticancer effects of chemotherapy drugs.

Since Donato Perez Garcia,MD (1896-1971) the creator on this treatment for cancer and chronic degenerative diseases started to treat patients, he set the treatment appointments for every 7 days, this was back in the year 1930 for chronic degenerative diseases and in 1946 for cancer. He noted that patients had very good responses when they received their chemotherapy every 7 days. It was the time when observation and good clinical judgment played an important factor. His observations came to scientific support until the year 2009 when a team of Medical Doctors (Coventry, Ashdown, Quinn, Markovic, Yatomi-Clarke & Robinson) from  Department of Surgery & Tumor Immunology Laboratory, University of Adelaide, Royal Adelaide Hospital, Adelaide South Australia identified the homeostatic immune oscillations in cancer patients that CR a protein indicated. This CRP is associated with inflammation and the activation of the immune system. (Journal of Translational Medicine 2009,7:102)

To my patients treated here in Tijuana, Baja California this means that they are receiving their chemotherapy protocol on the correct day, achieving the disruption of the regulatory circuits that protect the tumor cells.  With my IPTLD protocol my patients are also taking advantage of the induced and controlled hyperthermia that insulin produces and it is well known that a high body temperature also helps in the fight against cancer.
I started to treat cancer and chronic degenerative disease patients back in 1983 and during these 28 years or clinical practice I have seen several cancer patients that were initially treated with standard chemotherapy, responded well but later developed a cancer recurrence. Several of these patients who developed a metastases or recurrence were told that  they build chemo resistance. When I started to treat them using the low dose insulin that acts as a modifier of the cell biologic response with the same chemo drugs they received as their first treatment they all had a good response. No need to mention that the Greek test to detect chemotherapeutic drugs sensitivity was not available.

CONCLUSION: To over come resistance of chemotherapy drugs -when they stopped working- the pre-treatment administration of insulin as it is done on IPTLD, is the solution to enhance the effect of the chemotherapy drug, making the use of insulin an important one to deliver effectively your chemotherapy drug combination at the right time and day to match your immune system activity . If the problem of making the chemo drug effective is solved by the pre-treatment administration of insulin, the sensitivity test to different chemo agents may not be as necessary as you may think in order to treat metastases or recurrences, because when the drugs are given on the right time and day, the response is a success. I have seen this happen many times during my 28 years of clinical experience with IPTLD/IPT and no other IPT doctor can compete with my long clinical experience of doing IPT/IPTLD.

Award Presentation to Dr.Donato Perez Garcia, MD during The 14th Annual Conference of the Mexican College of Cellular Therapy and Regenerative Medicine

Mexico City. December 9, 2023. The 14th Annual Conference of the Mexican College of Cellular Therapy and Regenerative Medicine took place. I...